Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableLooking for participantsNCT06622954
What this trial is testing

Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients

Who this might be right for
CardiotoxicityBreast Cancer
Erasmus Medical Center 32
Large-scale testing (Phase 3)UnknownNCT01093235
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Who this might be right for
Breast CancerCardiac ToxicityPerioperative/Postoperative Complications
Cambridge University Hospitals NHS Foundation Trust 800
Large-scale testing (Phase 3)Study completedNCT03265574
What this trial is testing

PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?

Who this might be right for
Breast CancerNon Hodgkin Lymphoma
South Tees Hospitals NHS Foundation Trust 111
Not applicableStudy completedNCT02274480
What this trial is testing

Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity

Who this might be right for
Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT01009918
What this trial is testing

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Who this might be right for
Breast CancerCardiac Toxicity
University of South Florida 468
Testing effectiveness (Phase 2)Looking for participantsNCT07245069
What this trial is testing

Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Who this might be right for
Heart FailureAnthracycline-induced Cardiac ToxicityEndothelial Function (FMD)+2 more
University Medical Centre Ljubljana 100
Not applicableStudy completedNCT02423356
What this trial is testing

Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin

Who this might be right for
Breast NeoplasmsLymphomaSarcoma
Daniel Rushing 12
Testing effectiveness (Phase 2)Study completedNCT04737265
What this trial is testing

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

Who this might be right for
CardiotoxicityToxicity Due to ChemotherapyBreast Cancer+3 more
Abramson Cancer Center at Penn Medicine 101
Post-approval studies (Phase 4)Not Yet RecruitingNCT07254221
What this trial is testing

Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Anthracycline-induced Cardiac ToxicityBreast CancerAnthracycline Related Cardiotoxicity in Breast Cancer+1 more
Shiraz University of Medical Sciences 400
Not applicableLooking for participantsNCT07191730
What this trial is testing

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

Who this might be right for
CardiotoxicityHeart FailureNeoplasms+1 more
University Hospital, Caen 600
Large-scale testing (Phase 3)UnknownNCT05595109
What this trial is testing

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Who this might be right for
Breast CancerPeripheral NeuropathyCardiac Toxicities+2 more
Tanta University 56
Not applicableActive Not RecruitingNCT05078190
What this trial is testing

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer

Who this might be right for
Breast CancerCardiotoxicityDrug-Related Side Effects and Adverse Reactions+1 more
Abramson Cancer Center at Penn Medicine 200
Large-scale testing (Phase 3)Ended earlyNCT00247975
What this trial is testing

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

Who this might be right for
Heart Failure
Ottawa Heart Institute Research Corporation 36
Not applicableNot Yet RecruitingNCT07419711
What this trial is testing

Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity

Who this might be right for
Chemotherapy-induced CardiotoxicityBreast Cancer
Nazarbayev University 120
Early research (Phase 1)Study completedNCT04023110
What this trial is testing

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Who this might be right for
CardiotoxicityRisk Factor, CardiovascularToxicity Due to Chemotherapy+3 more
Abramson Cancer Center at Penn Medicine 68
Large-scale testing (Phase 3)UnknownNCT05728632
What this trial is testing

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

Who this might be right for
Breast CancerLymphoma, Large B-Cell, DiffuseCardiotoxicity+2 more
Giulio Stefanini 80
Not applicableNot Yet RecruitingNCT06595316
What this trial is testing

Exercise for Ameliorating Chemotherapy Cardiotoxicity

Who this might be right for
Cardiotoxicity
University of Hull 30
Not applicableStudy completedNCT00806507
What this trial is testing

Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 45
Not applicableStudy completedNCT01719562
What this trial is testing

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Who this might be right for
Cardiac ToxicityMalignant NeoplasmBreast Cancer
Wake Forest University Health Sciences 28
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Load More Results